Biocon Gains After Arm Enters Strategic Alliance With Serum Institute
Friday, September 17, 2021
Comment
Biocon Biologics will offer approximately 15 per cent stake to SILS, at a valuation of $4.9 billion.
from NDTV Profit - Latest https://ift.tt/3hZqctF
from NDTV Profit - Latest https://ift.tt/3hZqctF
0 Response to "Biocon Gains After Arm Enters Strategic Alliance With Serum Institute"
Post a Comment